0
USD
U.S. (TOLL FREE)
+1 (425) 388-2538
Automative

0
U.S. (TOLL FREE)
+1 (425) 388-2538

Emicizumab Launch Insight 2019

Published Date: February 2019
|
Report Code: DELV-Laun-22
Home | Category |Business & Industrial |Pharmaceuticals & Biotech
Emicizumab Launch Insight 2019

Emicizumab Launch Insight 2019

Code: DELV-Laun-22
Report
February 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight’s, “Emicizumab, Launch Insight, 2019” report provides comprehensive Insight about the Emicizumab's launch. The report covers all the indications for which the Emicizumab is being developed and also provides the competitive landscape for the major indications. The report further includes patent details, forecasted sales till 2022 and post launch market positioning.

The report will provide a clear picture of market positioning of the upcoming launch of Emicizumab and will also provide the insight about how Emicizumab will evolve in the market as well as within its respective class.Report provides detailed information of clinical trials that have been or are being conducted for this product. Analysis and Insightful information around the clinical trials is provided by assessment of the trial results.

Attribute analysis carried out by our analysts helps in understanding how the upcoming launch scores itself in comparison to other competitors (both marketed and pipeline). The scoring and analysis has been based upon scrutinizing data from all key clinical trials for the product. A head to head comparison with marketed products if available is scanned thoroughly. Further, analyzing data of other competitors with regards to the product also assists in proper scoring of the product in its space.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• Detailed product description including its chemical properties, molecule type and mechanism of action
• Detailed description of non-clinical and clinical studies for all the indications
• Patent expiry analysis of the drug along with other competitors in the market
• Forecasted sales till 2022
• Emicizumab market positioning analysis
• Emicizumab class share evolution

Report Introduction
Emicizumab Overview
Emicizumab of action
Pre-clinical Characterization
• Indication 1
• Indication 2
Clinical Characterization
• Indication 1
• Indication 2
Product Developmental Activities
• Collaboration
• Mergers & Acquisitions
• Financing
Emicizumab Market Evolution
Emicizumab Class Share Evolution
Emicizumab Market Positioning
Patent Expiry Analysis
Competitive Landscape for the Emicizumab in major indications
Appendix

List of Tables

Table 1: Emicizumab, Heat Map
Table 2: Clinical Trial Landscape
Table 3: Clinical Efficacy Data from Cross Trials
Table 4: Competitive Landscape for Emicizumab in Indication 1
Table 5: Competitive Landscape for Emicizumab in Indication 2

List of Figures

 Figure 1: Emicizumab Developmental Milestones
Figure 2: Emicizumab Sales Forecast till 2023
Figure 3: Emicizumab Class Share Evolution
Figure 4: Comparative analysis of Emicizumab with marketed products in the same class
Figure 5: Patent Expiry Analysis

 

DelveInsight’s, “Emicizumab, Launch Insight, 2019” report provides comprehensive Insight about the Emicizumab's launch. The report covers all the indications for which the Emicizumab is being developed and also provides the competitive landscape for the major indications. The report further includes patent details, forecasted sales till 2022 and post launch market positioning.

The report will provide a clear picture of market positioning of the upcoming launch of Emicizumab and will also provide the insight about how Emicizumab will evolve in the market as well as within its respective class.Report provides detailed information of clinical trials that have been or are being conducted for this product. Analysis and Insightful information around the clinical trials is provided by assessment of the trial results.

Attribute analysis carried out by our analysts helps in understanding how the upcoming launch scores itself in comparison to other competitors (both marketed and pipeline). The scoring and analysis has been based upon scrutinizing data from all key clinical trials for the product. A head to head comparison with marketed products if available is scanned thoroughly. Further, analyzing data of other competitors with regards to the product also assists in proper scoring of the product in its space.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• Detailed product description including its chemical properties, molecule type and mechanism of action
• Detailed description of non-clinical and clinical studies for all the indications
• Patent expiry analysis of the drug along with other competitors in the market
• Forecasted sales till 2022
• Emicizumab market positioning analysis
• Emicizumab class share evolution

Read More

Report Introduction
Emicizumab Overview
Emicizumab of action
Pre-clinical Characterization
• Indication 1
• Indication 2
Clinical Characterization
• Indication 1
• Indication 2
Product Developmental Activities
• Collaboration
• Mergers & Acquisitions
• Financing
Emicizumab Market Evolution
Emicizumab Class Share Evolution
Emicizumab Market Positioning
Patent Expiry Analysis
Competitive Landscape for the Emicizumab in major indications
Appendix

Read More

List of Tables

Table 1: Emicizumab, Heat Map
Table 2: Clinical Trial Landscape
Table 3: Clinical Efficacy Data from Cross Trials
Table 4: Competitive Landscape for Emicizumab in Indication 1
Table 5: Competitive Landscape for Emicizumab in Indication 2

List of Figures

 Figure 1: Emicizumab Developmental Milestones
Figure 2: Emicizumab Sales Forecast till 2023
Figure 3: Emicizumab Class Share Evolution
Figure 4: Comparative analysis of Emicizumab with marketed products in the same class
Figure 5: Patent Expiry Analysis

 

Read More

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$1500
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$3000
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$4500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)

RELATED REPORTS

Global Pharmaceutical Vial Market Professional Survey Report 2019
Global Pharmaceutical Vial Market Professional Survey Report 2019

Global Pharmaceutical Vial Market Professional Survey Report 2019

120 Pages
Type: Report
Code: QYRE-Auto-13Y558
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

Global Pharmaceutical Bottles Market Professional Survey Report 2019
Global Pharmaceutical Bottles Market Professional Survey Report 2019

Global Pharmaceutical Bottles Market Professional Survey Report 2019

120 Pages
Type: Report
Code: QYRE-Auto-35N324
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

Global Bio Based Molecule Market Professional Survey Report 2019
Global Bio Based Molecule Market Professional Survey Report 2019

Global Bio Based Molecule Market Professional Survey Report 2019

120 Pages
Type: Report
Code: QYRE-Auto-3Z733
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

Global Ribavirin CAS 36791 04 5 Market Insights Forecast to 2025
Global Ribavirin CAS 36791 04 5 Market Insights Forecast to 2025

Global Ribavirin (CAS 36791-04-5) Market Insights, Forecast to 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F293
Wed Nov 06 00:00:00 UTC 2019

Add to Cart

0 Items
X
No items in the cart.
$0.0